Podcasts about cms innovation center

Play Episode Listen Later Jan 2, 2023 65:51

For all of you leaders out there on a value-based care journey, it is not lost on any of you that health value has become synonymous with health equity. We are at an inflection point in our society in the recognition that everyone needs a fair and just opportunity to attain their highest level of health. Achieving this will require ongoing societal efforts to address injustice, overcoming socioeconomic barriers to health, and eliminating preventable health disparities. But we cannot do that as a healthcare industry without the proliferation and scale of payment models that align incentives so we can realize true change for the better. On the Race to Value this week, you will hear from one of the foremost leaders on the national scene who is shaping the landscape for accountable care delivery that can advances health equity. Dr. Dora Hughes is someone who has taken this charge to lead in service to the underserved so that we may realize the dream of a more equitable and healthy society. She is the chief medical officer at the CMS Innovation Center at the Centers for Medicare & Medicaid Services (otherwise known as CMMI). She leads the Center's work on health equity, provides clinical leadership and input on models, serves as the Innovation Center's primary liaison with medical and clinical stakeholders, and provides leadership to the Innovation Center's clinician community. In addition, Dr. Hughes is part of the CMS Innovation Center's Senior Leadership Team, helping to provide enterprise-level leadership and strategic direction to the Center. In this interview, we discuss the elevated national consciousness to advance health equity, how ACOs and other risk bearing entities can succeed with a health equity strategy, and the work being done by the Innovation Center to redesign alternative payment models for equity. We spend considerable time discussing ACO REACH and value-based Medicaid transformation as well. This is certainly a conversation you should listen to as you plan for success in your Race to Value! Episode Bookmarks: 01:30 Health Value has become synonymous with Health Equity -- everyone needs a fair and just opportunity to attain their highest level of health. 02:30 Introduction to Dora Hughes, M.D., M.P.H., the chief medical officer at the CMS Innovation Center (CMMI) 04:30 If you control for all variables that may contribute to health disparities, African Americans still get the worst quality of healthcare of any demographic in the country. 05:30 The first pillar of CMS' Strategy Plan is Health Equity 06:30 Cara James, Ph.D., president and CEO of Grantmakers in Health: "I'm someone who's working on equity before it became cool to work on equity." 07:00 Referencing the seminal findings of the Heckler Report in the 1980s that investigated racial and ethnic disparities in the United States. 08:00 Momentum has been building towards addressing health inequities, despite the historical lack of national prioritization. 08:30 “It really took the pandemic and police brutality to blast the issues of health inequities into the national consciousness.” 09:00 Disparities go beyond COVID (e.g. black disparities in maternal health, colorectal cancer, kidney disease) 09:45 “Executive pay is now being tied to reduction in disparities. You wouldn't have heard that 10 years ago or even perhaps five years ago.” 10:00 Referencing CCSQ Deputy Jean Moody-Williams: "For those of us engaged in health equity, this is our moment, but it is only a moment." 10:30 Actions Needed: collecting and analyzing demographic and health data, knowing patients individually and at the population level, identifying disparities, implementing evidence-based interventions. 11:45 “It takes vibrancy, resiliency, and an indomitable spirit to tackle disparities and scale progress at a national level.” 13:00 CMMI's work to address Social Determinants of Health (SDOH), e.g. ACOs, Accountable Health Communities (AHC) Model

The Role CMS Plays in Tackling HealthCare Challenges in America! | Ep. 17

Healthcare Trailblazers

Play Episode Listen Later Dec 26, 2022 43:53

We are super excited today to be joined by the chief strategy officer of CMS Innovation Center for Medicare & Medicaid Services, Purva Rawal. Purva will be sharing a bit about CMS, the agency's priority to drive innovation that tackles the health systems challenges, and Purva's role at CMS. About CMS In order to find ways to raise healthcare quality while lowering costs for the Medicare, Medicaid, and Children's Health Insurance Program (CHIP) programmes, Congress established the CMS Innovation Center in 2010. In response to this challenge, the CMS Innovation Center has sped up the transition from a healthcare system that pays for volume to one that pays for value through its models, projects, and Congressionally mandated demonstrations.The Centers for Medicare & Medicaid Services (CMS) Innovation Center, also known as “CMMI,” develops and tests new healthcare payment and service delivery models to:1. Improve patient care.2. Lower costs.3. Better align payment systems to promote patient-centered practices.Learn more about Purva Rawal:LinkedIn: https://www.linkedin.com/in/purva-rawal-9a49a21/Learn more about CMS: Website: https://innovation.cms.gov/about Learn more about Previva Health Group:Website: https://previva.com/ LinkedIn: https://www.linkedin.com/company/previva-health-group/

america children challenges healthcare congress plays lower tackling medicare centers medicaid cms medicaid services cmmi congressionally purva health insurance program chip cms innovation center

Accelerating Towards Action: Advancing Multi-Stakeholder Payment Reforms in Value Transformation, with Dr. Mark McClellan and Dr. Judy Zerzan-Thul

Play Episode Listen Later Dec 12, 2022 70:59

The Health Care Payment Learning & Action Network (HCP LAN or LAN) is an active group of public and private health care leaders dedicated to providing thought leadership, strategic direction, and ongoing support to accelerate our care system's adoption of alternative payment models (APMs). The LAN mobilizes payers, providers, purchasers, patients, product manufacturers, policymakers, and others in a shared mission to lower care costs, improve patient experiences and outcomes, reduce the barriers to APM participation, and promote shared accountability. Last month the LAN held their 2022 Summit, and this year's event featured appearances by CMS and CMS Innovation Center leadership, the release of the 2022 APM Measurement Effort results, a discussion on the HEAT's Social Risk Adjustment Guidance for APMs, and the announcement of the LAN's 2030 APM Adoption Goals for Medicare, Medicaid, and commercial plans. Joining us this week in the Race to Value are LAN Executive Forum Co-Chairs, Dr. Judy Zerzan-Thul and Dr. Mark McClellan. They discuss the overall goal of the LAN and the LAN Summit is to collaborate and act on strategies that will accelerate the transition to innovative, patient-centered payment models by focusing on equity, access to high-quality and affordable care, engagement of patients, and reduced provider burden. https://www.advancinghealthvalue.org/hpclan_summit_22/ Visit the Institute for Advancing Health Value's website. Download their recently released Intelligence Brief summarizing the 2022 LAN Summit. Visit the LAN's website: Learn more about 2020 & 2021 APM Measurement Efforts Consult the HEAT's APM Design Guidance  –  Advancing Health Equity Through APMs Episode Bookmarks: 01:30 The purpose of the Health Care Payment Learning & Action Network (HCP LAN) 03:00 Introduction to Dr. Mark McClellan and Dr. Judy Zerzan-Thul 05:45 Dr. Mark McClellan speaks to the impact of the pandemic on value-based health reforms 06:45 “Payment flexibilities are one of the unsung heroes in the pandemic when it comes to value transformation.” 07:15 How capitation enabled some to navigate the pandemic favorably, while others struggled with FFS revenue disruption, team-based care, and telehealth deployment. 08:45 CMS payment flexibilities will soon go away so prepare for continued focus on patient-longitudinal well-being and outcomes tracking. 09:45 The especially challenging times of high inflation and workforce resilience and how value transformation is a strategy for sustainability. 12:00 Dr. Zerzan-Thul speaks about the Accountable Care Commitment Curve and how that can guide organizations to advancements in Health Equity. 13:30 The LAN's Health Equity Advisory Team (HEAT) and its recommendations for developing a Health Equity action plan. 14:30 Measuring equity outcomes through an enhanced data infrastructure and community partnerships. 15:45 Dr. McClellan speaks to how Social Risk Adjustment (SRA) can advance health equity through APMs (starting with ACO REACH) 17:30 The challenges of implicit biases in individual measures of social risk. 18:15 “Risk factors like food insecurity and transportation will eventually get more built in to our approach to health care.” 19:00 The additional considerations of community engagement, peer transformation, and other payment incentives to advance health equity. 20:30 The recent release of the APM Measurement Effort (survey data compiled the HCP LAN). 21:30 Dr. McClellan discusses the current status of 2022 APM adoption (see interactive graphic showing that nearly 20% of payments flowing through Category 3B-4 models.) 24:30 Dr. Zerzan-Thul comments on trajectory of APM adoption and current status of Medicaid transformation in population-based payment. 27:00 Dr. McClellan discusses the Accountable Care Commitment Curve more at length. 29:00 “You can't get to a critical mass of value transformation in the U.S.

action race transformation risk institute heat summit payments measuring medicare advancing medicaid lan accelerating cms stakeholders reforms health equity mcclellan apm ffs apms thul aco reach cms innovation center zerzan

EP378: The Status of Telehealth Reimbursement and Other Telehealth Policy Updates, With Josh LaRosa, MPP

Play Episode Listen Later Sep 8, 2022 33:16

Okay, so … telehealth for Medicare patients. Currently, there's payment parity, meaning a clinician gets paid the same amount for a Medicare patient visit regardless of whether that patient comes in the office or has a telehealth encounter. Right? Or did that end already? And if it didn't end, how much longer will payment parity continue? Also, is it the same for commercial and Medicaid patients? Congress makes rules for Medicare patients, but is it Congress that makes the rules for commercial and/or Medicaid telehealth reimbursement rates? Or how do those reimbursement decisions get made? What about the doing telehealth across state lines thing … the idea that if I'm a doc in New York, I can take a telehealth appointment with a patient in Arizona even though I am technically not licensed in Arizona? And who's in charge of that? Yeah, I went into today's conversation with Josh LaRosa, VP at Wynne Health Group, with a lot of questions. As you may suspect, this program is about telehealth. But just to level set on what we're not talking about, this interview does not dissect the “should we use the telehealth or should we not” question; and it does not get into best practices or equity concerns. For that info, listen to the show with Christian Milaster (EP320) or Liliana Petrova (EP357) or Ali Ucar (EP362) or Ian Tong, MD (EP347). Also, we are not talking about the politics, per se, of who's for telehealth and who's against it. We also aren't drilling too far into the telehealth fraud cases that are coming to light right now, but of course we cannot resist talking about them a little bit. So, let me tell you what Josh LaRosa and I are, in fact, talking about in this healthcare podcast. We're specifically discussing the near-term future of CMS reimbursement for telehealth and the allowed so-called “flexibilities” for telehealth. We talk about a few of the why's behind why are policy makers doing some of the stuff that they are doing. And then we chat about the when, how long some of the new flexibilities and reimbursements that were permitted originally during the pandemic will continue. We touch on the Cerebral incident (I guess maybe you'd call it) and the potential DEA or legislative actions that may result from that as well. An interesting point that we dig into for a couple minutes is this one: Do not forget that the whole telehealth reimbursement debate (do I wanna call it?)—Should we cover it? Should we not cover it? And for how much?—this whole debate is part of a bigger debate. A much bigger debate, actually: the fee-for-service vs the not-fee-for-service debate. That's the larger context of all of this, and I think it's often overlooked. Nobody anywhere is limiting how often a practice who wants to use telehealth as part of some kind of risk-based or capitated thing can use telehealth. Why? Because in a capitated or bundle arrangement, from a Medicare trust fund perspective at least, telehealth visits are not equivalent to additional spend or additional volume. In a non-FFS environment, there's little chance of fraud also, really. Also, patient safety—arguably, probably—becomes much more of a practice concern. It gets a lot less rewarding to do unsafe things over telehealth when you don't get automatically paid to do them … and also paid to fix the problems that resulted from the unsafe things, which is the perverse beauty of FFS that we're all so familiar with. Acronym alert! PHE stands for public health emergency. A public health emergency is the thing the government declares, for example, during a pandemic. You can learn more at wynnehealth.com or by following on Twitter and LinkedIn. Josh LaRosa, MPP, is a vice president at Wynne Health Group, focusing primarily on regulatory affairs with a focus on the US Food & Drug Administration (FDA) and Centers for Medicare & Medicaid Services (CMS). His interests lie in delivery reform and innovations in payment and care delivery models. Josh also supports the firm's Public Option Institute, which studies the emergence of public option programs at the state level. Prior to Wynne Health Group, Josh consulted for the CMS Innovation Center, where he worked to implement, monitor, and spread learning garnered from the center's high-profile demonstration projects, most recently including the national primary care redesign effort, Comprehensive Primary Care Plus (CPC+). Josh holds a Master of Public Policy from the University of Virginia's Frank Batten School of Leadership and Public Policy. He also completed his undergraduate studies at the University of Virginia, graduating cum laude with a BA in political philosophy, policy, and law. 04:09 What is the story with telehealth policy right now? 06:08 What kind of flexibilities did HHS allow with telehealth after the pandemic? 09:46 Are we still under these pandemic flexibilities for telehealth? 12:15 Why isn't the government just making greater access to telehealth permanent? 18:24 How does telehealth lend itself to the risk of overspending when dealing with an FFS model? 21:13 Does telehealth fit into the new CMS fee schedule? 22:55 How do states factor into the future of telehealth? 24:40 What is Arizona doing specifically to improve and ensure the future of telehealth? 30:56 What's next in store for telehealth at the congressional level? You can learn more at wynnehealth.com or by following on Twitter and LinkedIn. @josh_larosa of @WynneHealth discusses #telehealth on our #healthcarepodcast. #healthcare #podcast #digitalhealth What is the story with telehealth policy right now? @josh_larosa of @WynneHealth discusses #telehealth on our #healthcarepodcast. #healthcare #podcast #digitalhealth What kind of flexibilities did HHS allow with telehealth after the pandemic? @josh_larosa of @WynneHealth discusses #telehealth on our #healthcarepodcast. #healthcare #podcast #digitalhealth Are we still under these pandemic flexibilities for telehealth? @josh_larosa of @WynneHealth discusses #telehealth on our #healthcarepodcast. #healthcare #podcast #digitalhealth Why isn't the government just making greater access to telehealth permanent? @josh_larosa of @WynneHealth discusses #telehealth on our #healthcarepodcast. #healthcare #podcast #digitalhealth How does telehealth lend itself to the risk of overspending when dealing with an FFS model? @josh_larosa of @WynneHealth discusses #telehealth on our #healthcarepodcast. #healthcare #podcast #digitalhealth Does telehealth fit into the new CMS fee schedule? @josh_larosa of @WynneHealth discusses #telehealth on our #healthcarepodcast. #healthcare #podcast #digitalhealth How do states factor into the future of telehealth? @josh_larosa of @WynneHealth discusses #telehealth on our #healthcarepodcast. #healthcare #podcast #digitalhealth What is Arizona doing specifically to improve and ensure the future of telehealth? @josh_larosa of @WynneHealth discusses #telehealth on our #healthcarepodcast. #healthcare #podcast #digitalhealth What's next in store for telehealth at the congressional level? @josh_larosa of @WynneHealth discusses #telehealth on our #healthcarepodcast. #healthcare #podcast #digitalhealth Recent past interviews: Click a guest's name for their latest RHV episode! Stacey Richter (INBW35), Rebecca Etz (Encore! EP295), Olivia Webb (Encore! EP337), Mike Baldzicki, Lisa Bari, Betsy Seals (EP375), Dave Chase, Cora Opsahl (EP373), Cora Opsahl (EP372), Dr Mark Fendrick (Encore! EP308), Erik Davis and Autumn Yongchu (EP371), Erik Davis and Autumn Yongchu (EP370), Keith Hartman, Dr Aaron Mitchell (Encore! EP282), Stacey Richter (INBW34), Ashleigh Gunter, Doug Hetherington, Dr Kevin Schulman, Scott Haas, David Muhlestein, David Scheinker, Ali Ucar, Dr Carly Eckert, Jeb Dunkelberger (EP360), Dan O'Neill, Dr Wayne Jenkins, Liliana Petrova, Ge Bai

Evaluating the AHC Model

Play Episode Listen Later Aug 5, 2022 13:14 Transcription Available

Find all supporting materials at the Hunger Vital Sign explainer series website.This episode features an interview with Katherine Verlander, Deputy Division Director at the Centers for Medicare & Medicaid Services (CMS)Part One of this series featured Children's HealthWatch - find their Hunger Vital Sign materials and background research here.Part Two of this series featured Hunger Free Vermont and their work implementing Hunger Vital Sign in Vermont.Part Three of the series introduces the screening, referral, and navigation services evaluated as part of the Accountable Health Communities Model at the CMS Innovation Center.Audio Editing and Post-Production Provided By Evergreen Audio

children model healthcare nutrition vermont medicare evaluating centers audio editing healthwatch cms innovation center

Introduction to Part 3: Accountable Health Communities

Play Episode Listen Later Aug 5, 2022 5:19 Transcription Available

The Hunger Vital Sign explainer series continues with an introduction to the Accountable Health Communities (AHC) Model at the CMS Innovation Center. This model is testing the results of screening for health-related social needs and offering referral and navigation services to community resources in a health care setting. The Hunger Vital Sign questions make up the food security portion of the AHC screening tool, and food insecurity has been the most common identified need. The guest expert for this section is Katherine Verlander, Deputy Division Director at the Centers for Medicare and Medicaid Services (CMS).Please visit our Hunger Vital Sign explainer series website for reference materials and resources connected to these interviews.

health healthcare nutrition communities medicare centers accountable medicaid services cms ahc cms innovation center

The CMS Innovation Center

Play Episode Listen Later Aug 5, 2022 14:18 Transcription Available

Find all supporting materials at the Hunger Vital Sign explainer series website.This episode features an interview with Katherine Verlander, Deputy Division Director at the Centers for Medicare & Medicaid Services (CMS)Part One of this series featured Children's HealthWatch - find their Hunger Vital Sign materials and background research here.Part Two of this series featured Hunger Free Vermont and their work implementing Hunger Vital Sign in Vermont.Part Three of the series introduces the screening, referral, and navigation services evaluated as part of the Accountable Health Communities Model at the CMS Innovation Center.Audio Editing and Post-Production Provided By Evergreen Audio

children healthcare nutrition vermont medicare centers audio editing healthwatch cms innovation center

The Accountable Health Communities Model

Play Episode Listen Later Aug 5, 2022 17:34 Transcription Available

Find all supporting materials at the Hunger Vital Sign explainer series website.This episode features an interview with Katherine Verlander, Deputy Division Director at the Centers for Medicare & Medicaid Services (CMS)Part One of this series featured Children's HealthWatch - find their Hunger Vital Sign materials and background research here.Part Two of this series featured Hunger Free Vermont and their work implementing Hunger Vital Sign in Vermont.Part Three of the series introduces the screening, referral, and navigation services evaluated as part of the Accountable Health Communities Model at the CMS Innovation Center.Audio Editing and Post-Production Provided By Evergreen Audio

health children model healthcare nutrition communities vermont medicare centers accountable audio editing healthwatch cms innovation center

EP376: Interoperability—Who's Who and Doing What? With Lisa Bari, MBA, MPH

Play Episode Listen Later Aug 4, 2022 34:11

Interoperability. Let's just review a few key points that probably everybody listening knows but certainly bear repeating because they matter. I don't want to dig into the technical or regulatory details of interoperability. That is above my pay grade. But I want to talk about the really important stuff that maybe doesn't get talked about a whole lot because you say the word interoperability and it's like the magic word that transports the unwary into the land of shadow and smoke and mist. It's like a self-published YA (young adult) novel half the time. But let's start here: First of all, consider that a lot of healthcare these days is conceived of as a scattering of micro-moments. It's not even like we think of patients one at a time. We think about patients one ICD-10 code at a time. And we think about those ICD-10 codes in 20-minute increments whenever a patient happens to show up in clinic. The average Medicare patient these days sees five specialists and more than one PCP a lot of times. So, we're not only breaking that patient down into codes per minute or something, but this is further broken down by clinician or practice. Now consider that everybody knows—and when I say everybody knows, I mean it's inarguable at this point—health happens at the whole-patient level, at the whole-person level, more accurately. It happens at the community level: 80% of patient outcomes are going to derive from what that patient does when they leave the office and whether they are able to and health literate enough to construct a reconciled treatment plan for themselves from the bits and pieces of information they've received scattered all over the place. You know in Star Trek when someone gets into the transporter to beam down to a planet and their whole body splinters into a gazillion little pieces? That's how our healthcare industry treats patients. They are frozen in that moment and rarely, if ever, become whole on the other side. So, when we talk about interoperability, what we're really talking about is a means to an end. What we are discussing is creating the ability to treat the whole patient or—Heaven forbid!—consider the whole community because we have enough data that we can accurately and adequately see the whole picture. We are able to avoid prescribing a treatment that is dangerous to the patient, inefficient, duplicative, or low quality—which is what happens over and over again. It's no amazing surprise that our healthcare industry wastes $1 in $4 we spend and doesn't net outcomes that are great in almost any respect when compared to other countries. Let me say this more bluntly, as if that wasn't already pretty blunt: If I don't know relevant and important details about my patient, then I cannot consistently deliver care that is high quality, safe, or cost conscious due to service duplication or uncoordinated care. I mean, how is anybody supposed to deliver evidence-based care when a lot of evidence may or may not be missing? So basically, without interoperability piping in the right patient information, I cannot succeed in any risk-based arrangement, right? If care provided is consistently lower quality, uncoordinated, unsafe, or inefficient, how am I supposed to optimize my care delivery? Said another way, interoperability is essential for anybody who wants to succeed in a value-based arrangement. I need all the data on my patients, and I need it in a way that I can separate the signal from the noise. Of course, getting 40 pages of duplicative SOAP (subjective, objective, assessment, and plan) notes that are semi-accurate and that no one bothers to look at is just unhelpful. Quick counterpoint: FFS (fee for service) loves siloed data. You know how much money everybody talks about could be saved if we eliminate duplicative services? Well, that's how much some fee-for-service health system is gonna lose if you make it easy for clinicians to see that the patient already got that CAT scan. So, in sum, interoperability is essential to high-quality, safe, and efficient care. A mark of a health system or provider practice who is really committed to patient outcomes is going to be their commitment to share data. The world has moved from a “Hey, you're permitted to share data if you really want to” to a “You are obligated to share your data.” And right now, I am loosely quoting Micky Tripathi, PhD, MPP, who is the ONC's (Office of the National Coordinator for Health Information Technology) national coordinator and also the guy in charge of TEFCA (Trusted Exchange Framework and Common Agreement) and implementing the provisions against information blocking that was in the Cures Act Final Rule last year. In this healthcare podcast, I am speaking with the perfect person about interoperability, and that would be Lisa Bari, who is the CEO of Civitas Networks for Health, which is a national collaborative working to improve interoperability in this country to improve health. Since interoperability is a huge topic, what I wanted to understand from Lisa most particularly are: Who are the current roster of players in the interoperability space? Like, what is going on there? Lisa told me that there are four main groups of interoperability folks—EHR (electronic health record) systems; APIs (application programming interfaces); HIEs (health information exchanges), both profit and nonprofit; and then others like clearinghouses, etc—which we talk about in some detail in this episode. We also discussed Larry Ellison's bold proclamation that Cerner is going to build one national medical records database. It's almost like Larry made it through the “welcome to the healthcare briefing” packet that his team gave him and immediately concluded that the interoperability problem is a technology problem, not a business case, fee-for-service, workflow, no universal ID, human, organizational, or government problem. Lisa adds some fidelity there. Also, TEFCA … we talk about what it is and what it's not. Short version: It's a framework so that no one can say they won't share data lest they get in trouble in some way. At the same time, it's not gonna solve, as Lisa puts it, “the last mile of interoperability,” meaning it's not going to put the right information in the right clinician's hands at the right time. It just governs getting data from one organization to another organization but kinda has nothing to do with the clinical workflow, so to speak. The Civitas Networks for Health annual conference, by the way, is coming up on August 21-24 if you are interested in going. You can learn more at civitasforhealth.org. Lisa Bari, MBA, MPH, is the inaugural CEO of Civitas Networks for Health, a national nonprofit member- and mission-driven organization that was previously known as the Network for Regional Health Improvement and the Strategic Health Information Exchange Collaborative. Civitas counts over 100 multi-stakeholder-governed regional health improvement collaboratives and health information exchanges as members and creates national opportunities for education and community building between its members, policy makers, and business partners. Their upcoming conference (August 21-24, 2022, in San Antonio or via livestream) focuses on the theme of data collaboratives and information exchanges creating the critical infrastructure for health equity. Previously, Lisa was the health IT and interoperability lead at the CMS Innovation Center, working on primary care innovation model policy, and additionally has a background in health IT marketing and strategy. She holds an MBA from Purdue University and a Master of Public Health in health policy from the Harvard TH Chan School of Public Health and serves on the boards of directors of HealthCare Access Maryland and the Zorya Foundation. 06:30 How does value-based care depend on interoperability? 07:38 Why is it really important to exchange information at the right time with the right purpose? 08:00 What is one of the easiest low-hanging fruit to achieve in value-based care? 09:42 What are the four kinds of companies getting into the interoperability space? 11:51 “As we know, there's sort of technical interoperability … and then there's semantic interoperability.” 12:59 Where are we right now with EHR basic interoperability? 15:33 Who should ACOs hire to get the right data at the right time? 17:00 Why is it important to delineate the different types of HIE? 22:09 What can ACOs assure with interoperability? 22:59 Is the demand among ACOs for interoperability there? 24:04 “If you're in value-based care, you better care about what's happening outside of the healthcare setting.” 24:36 EP108 with Chris Klomp.26:25 “Every couple of years, someone talks about creating the ultimate database to rule them all. … It hasn't happened yet, and I don't think it's going to happen.” 26:56 “The difficult thing about healthcare data … interoperability … is an organizational and a governance problem.” 28:49 “You've gotta start with the incentives … and then you do have to say … ‘We are not gonna hoard any more data.'” 29:10 What is TEFCA, and how does it fit into this interoperability conversation? 32:17 “I think partners are trying to solve for value and outcomes.” You can learn more at civitasforhealth.org. @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth How does value-based care depend on interoperability? @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth Why is it really important to exchange information at the right time with the right purpose? @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth What is one of the easiest low-hanging fruit to achieve in value-based care? @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth What are the four kinds of companies getting into the interoperability space? @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth “As we know, there's sort of technical interoperability … and then there's semantic interoperability.” @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth Where are we right now with EHR basic interoperability? @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth Who should ACOs hire to get the right data at the right time? @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth Why is it important to delineate the different types of HIE? @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth What can ACOs assure with interoperability? @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth Is the demand among ACOs for interoperability there? @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth “If you're in value-based care, you better care about what's happening outside of the healthcare setting.” @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth “Every couple of years, someone talks about creating the ultimate database to rule them all. … It hasn't happened yet, and I don't think it's going to happen.” @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth “The difficult thing about healthcare data … interoperability … is an organizational and a governance problem.” @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth “You've gotta start with the incentives … and then you do have to say … ‘We are not gonna hoard any more data.'” @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth What is TEFCA, and how does it fit into this interoperability conversation? @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth “I think partners are trying to solve for value and outcomes.” @lisabari of @civitas4health discusses #interoperability on our #healthcarepodcast. #healthcare #podcast #digitalhealth Recent past interviews: Click a guest's name for their latest RHV episode! Betsy Seals (EP375), Dave Chase, Cora Opsahl (EP373), Cora Opsahl (EP372), Dr Mark Fendrick (Encore! EP308), Erik Davis and Autumn Yongchu (EP371), Erik Davis and Autumn Yongchu (EP370), Keith Hartman, Dr Aaron Mitchell (Encore! EP282), Stacey Richter (INBW34), Ashleigh Gunter, Doug Hetherington, Dr Kevin Schulman, Scott Haas, David Muhlestein, David Scheinker, Ali Ucar, Dr Carly Eckert, Jeb Dunkelberger (EP360), Dan O'Neill, Dr Wayne Jenkins, Liliana Petrova, Ge Bai, Nikhil Krishnan, Shawn Rhodes, Pramod John (EP353), Pramod John (EP352), Dr Eric Bricker

S4 Ep7: Evolving Landscape for Diverse Clinical Trials: Legislation, Community & Stakeholders

Reducing Patient Risk

Play Episode Listen Later Jul 11, 2022 63:47

The "Evolving Landscape for Diverse Clinical Trials: Legislation, Community & Stakeholders" topic was originally presented at the 2022 National Minority Quality Forum Annual Leadership Summit on Health Disparities and Health Braintrust. Listen now for a closer look at addressing existing disparities. Panelists: Mark Fleury, PhD, Policy Principal, American Cancer Society Cancer Action Network (ACS-CAN) Lloryn Hubbard, Associate Director, Lead-Patient Diversity Clinical Research PPD, part of Thermo Fisher Scientific Salvatore (Salvo) Alesci, MD, PhD, Chief Scientist & Strategy Officer, Beyond Celiac Maha Radhakrishnan, MD Group, Senior Vice President & Chief Medical Officer, Biogen Dora Hughes, MD, MPH, Chief Medical Officer, The CMS Innovation Center at the Centers for Medicare and Medicaid Services Christina Edwards, MHA Clinical Trials Director National Minority Quality Forum (Moderator)

community phd md landscape evolving senior vice president medicare diverse centers associate director legislation mph chief medical officers stakeholders clinical trials chief scientist health disparities strategy officer cms innovation center

The Long Road to Health Care Transformation: Aligning the Public and Private Sector in Value, with Jeff Micklos

Play Episode Listen Later Mar 28, 2022 78:44

Jeff Micklos is the Executive Director of the Health Care Transformation Task Force, an industry consortium that brings together patients, payers, providers and purchasers to align private and public sector efforts to clear the way for a sweeping value transformation of the U.S. health care system. Under Jeff's leadership, the Task Force provides a critical mass of business, operational and policy expertise from the private sector that, when combined with the efforts of the Centers for Medicare & Medicaid Services and other public and private sector stakeholders, can accelerate the pace of delivery system transformation. Jeff is a great ally in this Race to Value, and the Task Force is doing its part to catalyze value-based payment adoption. In January 2015, the task force was formed based on a commitment to the triple objective of better care, better health and lower costs. As a unique private sector coalition under Jeff's executive leadership, the task force has an unrelenting vision to accelerate the pace of value-based care transformation. Consequently, they have set the goal for payer and provider members in the Task Force to have 75% of their business in value-based payment arrangements by the end of 2025. Listen to this episode to learn everything you need to know about the health policy landscape, strategic implications for payment and delivery transformation, and how redesigned payment models will help us seek sustainable improvements in health equity, patient outcomes, and consumer experience. Episode Bookmarks: 01:40 Introduction to Jeff Micklos and the Health Care Transformation Task Force 03:30 The grim stats on the U.S. health system and the need to accelerate value-based care transformation 05:00 “Change is hard. And change is even more difficult when the status quo is so lucrative in fee-for-service medicine.” 05:30 30% of fee-for-service healthcare is related to low-value care (changing this is a major opportunity to sustain in the long-term!) 05:45 Changes to payment models and the market-driving force of Medicare reforms in healthcare transformation 06:00 HCTTF Transformation Goal: 75% of members operating under value-based payment arrangements by 2025 (progress made by reaching 61% in 2020) 06:55 CMS Innovation Center (CMMI) Strategy Refresh Target Goal: All Medicare FFS beneficiaries in a accountable care relationship by 2030 07:15 “A financial spend metric (in and of itself) is not an indicator of success in value transformation.” (qualitative measures just as important!) 08:20 COVID-19 has only emphasized the need for significant payment and delivery transformation 09:30 The uncertain political climate and how that is shaping current delivery system reform efforts and private sector momentum for value-based transformation 10:00 Extension of the MACRA 5-percent Advanced APM incentive payment (currently scheduled to sunset in 2024) 11:00 The Build Back Better Act and its potential impact on improving health care and lowering costs 11:30 Increased coverage in the ACA marketplace exchanges as a success of the Biden Administration 11:50 The impact of the Russia-Ukraine situation on advancing health policy objectives in the near term 12:00 The upcoming midterm election and how the projected electorate change towards full GOP control may shift the political dynamics of the value movement 12:45 The CMMI Strategy Refresh as a guidepost for the future direction of the value movement 15:00 Reflecting back on the 1st 10 years of the CMS Innovation Center and lessons learned from theMedicare Shared Savings Program (MSSP) 15:50 “ACOs overall have played a key role in transforming the health care system by creating incentives for providers to deliver high quality, cost efficient care.” 16:10 Leveraging MSSP as a platform to scale provider adoption of other APMs 16:45 The failure to reach rural areas with APMs and the need for continued investmen...

Culturally Competent Leadership to Eliminate Disparities in Healthcare, with John W. Bluford, III, MBA, FACHE

Play Episode Listen Later Feb 14, 2022 65:08

This week we are honored to have as our guest, the legendary John W. Bluford III. Mr. Bluford is a nationally known healthcare innovator who has been recognized by Modern Healthcare and Becker's Hospital Review as one of the Most Influential People in Healthcare. Mr. Bluford is the Founder and President of the Bluford Healthcare Leadership Institute (BHLI) – a nonprofit organization focused on value-based care leadership to eliminate health care disparities. BHLI provides an intense professional development program designed to expose undergraduate scholars with exceptional leadership potential to today's challenging healthcare landscape, cultivating them for future leadership roles where they will serve to eliminate disparities in healthcare. This Institute was created by John Bluford as a way to advance health equity in today's healthcare system by sponsoring, mentoring, and coaching underrepresented talent for healthcare leadership and creating opportunities for the emerging leaders to improve health outcomes for minority and vulnerable populations. In this episode, you are going to learn from John Bluford how “Culturally Competent Leadership to Eliminate Disparities in Healthcare.” Mr. Bluford currently serves on the Board of Trustees for Western Governors University – the leading online university in the country with a College of Health Professions that is deeply involved in the provision of workforce readiness to deliver on the promise of high value, high quality care that delivers equitable outcomes for all. https://www.blufordinstitute.org Episode Bookmarks: 01:45 Introduction to the legendary John W. Bluford III, MBA, FACHE 03:10 The Bluford Healthcare Leadership Institute (BHLI) program's commitment to culturally competent leadership 07:45 Lessons learned from a 6-week experience at Harvard University that informed a new way of thinking about healthcare 09:00 The rewarding experiences as a mentor while serving as a preceptor for graduate students 10:00 Mr. Bluford never mentored minority students in 12 years as a preceptor because there weren't any at the time! 11:00 A vision to create a more diverse pipeline of healthcare administration students 12:00 “Our mission is to create leaders of the future that will eliminate health care disparities among minority and vulnerable patient populations over the next two generations.” 13:00 The impact of BHLI alumni leaders who have completed the program 16:00 The observance of Black History Month and the cultural zeitgeist for civil rights and social justice has been awakened in the collective consciousness of all ethnicities 17:30 Why institutional racism will take generations to fix because it is so deeply embedded in our country's history 18:40 “The accomplishments of Black Americans should be celebrated routinely just like everyone else. Black history is American history and should be treated as such.” 20:45 How the CMS Innovation Center is integrating health equity into the design and reengineering value-based payment models 22:15 The elevation of national consciousness regarding the existence of health disparities 22:45 “We can't fix the problem without realizing that there is a problem. Health care disparities do, in fact, exist.” 23:00 The need for strong, pervasive leadership in healthcare, society, and government to overcome the systematic perpetuation of racism 24:20 The role of hospitals in addressing health equity and population health in the communities they serve 26:45 Mr. Bluford discusses the importance of culturally competent leadership, reflecting on lessons learned from his hospital administration career 28:00 Understanding the culture of communities and how socioeconomic determinants of health impact care outcomes 29:50 Love, hope, and compassion needed in population health leadership 30:30 Case management of patients with chronic disease is more effective when you understand SDOH barri...

45: Partnership for Transformation with Elizabeth Fowler, Ph.D., J.D., Deputy Administrator and Director of the CMS Innovation Center

The Gary Bisbee Show

Play Episode Listen Later Jan 20, 2022 31:28

Meet Elizabeth Fowler:Elizabeth Fowler, J.D., Ph.D. is the Deputy Administrator and Director of the Center for Medicare and Medicaid Innovation (CMS Innovation Center). Previously, she was Executive Vice President for Programs at the Commonwealth Fund and served as Vice President for Global Health Policy at Johnson & Johnson. She received a Ph.D. in Health Policy from the Johns Hopkins Bloomberg School of Public Health, and a law degree from the University of Minnesota.Key Insights:The Innovation Center generates and tests new approaches for payment and delivery. It works to move the health system away from fee-for-service and towards a system that rewards better outcomes for patients.The Innovation Center's Priorities. The top 5 priorities of the Innovation Center are driving accountable care, advancing health equity, supporting care innovation, improving access by addressing affordability, and creating partnerships with public and private entities to achieve transformation. (9:27)The Speed of Innovation. Healthcare transformation is a marathon, not a sprint. It takes around 18 months to two years to conceptualize and implement an innovation model, and three to five years to collect meaningful results. (12:36)Patient at the Center. Dr. Fowler emphasizes that innovation should result in better outcomes for the patient. The Innovation Center conducted focus groups to determine the metrics most important to patients, and to better communicate innovation in relatable terms. (23:57) Relevant Links: Learn more about the Innovation CenterRead Dr. Fowler's articles from The Commonwealth FundFollow the Innovation Center on Twitter

Driving Health Value Transformation: A Strategy for the CMS Innovation Center's Second Decade, with Elizabeth Fowler

HealthcareNOW Radio - Insights and Discussion on Healthcare, Healthcare Information Technology and More

Play Episode Listen Later Jan 10, 2022 58:13

As it is entering its second decade, the Center for Medicare and Medicaid Innovation (CMMI) has launched a bold new strategy for achieving equitable outcomes through high quality, affordable, person-centered care. To achieve this vision, the Innovation Center has organized around five objectives: Drive Accountable Care, Advance Health Equity, Support Innovation, Address Affordability, and Partner to Achieve System Transformation. Over the last decade, CMMI has been the driving force for value-based care at the federal level and launched more than 50 alternative payment models. In the next decade, CMMI will apply lessons learned in establishing this strong foundation to lead the way towards broadened and more equitable health system transformation in our country. The ultimate goal is to have all Medicare beneficiaries in a care relationship with accountability for quality and total cost of care by 2030. Our guest this week is Liz Fowler, J.D., Ph.D., the director of the Center for Medicare and Medicaid Innovation (CMMI) and deputy administrator of the Centers for Medicare and Medicaid Services at the U.S. Department of Health and Human Services. She is leading CMMI in an effort to streamline the model portfolio and reduce complexity and overlap, and to help scale what works. From reengineering payment policies, to overcoming the complexities of model design that impede scalable transformation, and considering equity in all stages of model development – it is clear that health value remains a top priority for the Biden administration. Join us this week as we explore model design, equity, benchmarking, capital investment, beneficiary engagement and more. Dr. Fowler is truly leading the charge in the race to value! Read the transcript here. Read the CMS Innovation Center Strategy Refresh here. Episode Bookmarks: 02:00 An introduction to Liz Fowler's background in health policy leadership and industry transformation 03:00 Referencing the Innovation Center Strategy Refresh, a bold new strategy with the goal of achieving equitable outcomes through VBC 04:00 The need to reexamine the CMMI portfolio of APMs 06:40 Applying lessons learned over the last decade of CMMI to inform future payment models 07:00 “We have to have a cohesive articulation of a model portfolio, and explain how all the CMMI payment models fit together. That's what we're trying to do with our new strategy.” 07:30 Do the models support objectives? (i.e. drive accountable care, advance health equity, support innovation, address affordability, or achieve system transformation) 08:50 Healthy People 2030 defines health equity as “the attainment of the highest level of health for all people.” 10:15 Dr. Fowler describes how CMMI is embedding health equity into all aspects of payment model design (“Advancing health equity has become one of the most important areas of focus for the Innovation Center, and for CMS and HHS more broadly.”) 12:50 Dr. Fowler discusses how CMMI's strategy to focus on equity to promote accountable care extends to Medicaid. 14:15 Referencing the CMMI Health Equity Roundtable last month (download slides here) 14:30 Conducting focus groups with providers and patients to better understand what equity means to them 16:40 Dr. Fowler discusses how CMMI will moving more Medicaid and Medicare Advantage beneficiaries into accountable care relationships (CMMI's 2030 Goal) 18:20 Engaging local leaders to provide more care at the community level in addressing social needs (Accountable Health Communities Model) 19:30 The importance of creating the right incentives to address social determinants of health and the right tools to remove them as well 19:50 Data collection and measurement to assess health equity performance in value-based payment 22:10 Dr. Fowler discusses the importance of capital investment for providers to succeed in taking downside risk.

The Virtual Shift: Purva Rawel, PhD Chief Strategy Officer CMS Innovation Center

Play Episode Listen Later Nov 26, 2021 28:02

Host Tom Foley invites Purva Rawal, Chief Strategy Officer for the CMS Innovation Center to discuss the newly released white paper on CMS Innovation Center's Strategy: Driving Health System Transformation - A Strategy for the CMS Innovation Center's Second Decade. The Center, having taken stock of lessons learned from its first decade and 50+ models, is charting a path for the next ten years of value-based care -- one that will improve the health system for all patients. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play HealthcareNOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

virtual shift chief strategy officer smart device purva second decade cms innovation center

Medicare Meet-up with Dawn Alley

Medicare Meet-Up

Play Episode Listen Later Aug 12, 2021 38:46

Brede Eschliman, Meg Koepke, MHA and Melissa Cohen recap what they have learned from their guests on this season finale of the Medicare Meet-up as well an in depth discussion of the past, present and future of the CMS Innovation Center with former CMMI Chief Strategy Officer, Dawn Alley.

medicare meetup alley mha cms innovation center

EP317: Wait, the Latest Action on Drug Pricing Reform Can Be Found in the Infrastructure Bill? With Josh LaRosa, MPP, Policy Director, Wynne Health Group

Play Episode Listen Later Apr 8, 2021 26:38

Let’s get a fast bead on what’s going on with drug pricing reform, shall we? Every time I wade into these waters, my head about explodes. So, I very much appreciate the opportunity to quiz Josh LaRosa from the always-well-informed Wynne Health Group. Here’s the goings-on in a nutshell: There’s goings-on. This infrastructure bill that’s in all the news all over the place right about now? You know what the plan is to fund all those bridges? Yeah, well, part of it is for Medicare to save money on drugs and then apply the savings to cover the costs of all those roads and train tunnels. There are three major potential ways that the federal government might conceive of collecting these drug savings: (1) They could try to get others to pick up some of the Medicare Part D costs—others meaning private payers and pharma manufacturers. (2) Also, they can limit how much manufacturers could raise prices via this “inflation rebate” proposal. Interestingly, this “you can’t raise prices more than the rate of inflation or else you have to rebate the difference” legislation is also being bandied about for Medicare Part B (as in boy) drugs. And those Part B drugs? Those are frequently the really expensive ones (ie, the oncology meds that are infused). And then the third way (3) to save some shekel that might wind up in the infrastructure bill is permitting HHS (the Department of Health and Human Services) to negotiate for drug prices. This last one is always a hot potato, but the winds might be changing some. On the Executive Branch front, we also may have a reboot of the Most Favored Nation rule, but I’ll let Josh explain that one. In fact, I’ll let Josh explain the brouhaha on all of these possibilities. For more information on any of this, read the article that Josh LaRosa and his Wynne Health Group colleagues wrote for The Commonwealth Fund blog recently. You can learn more at wynnehealth.com or by following on Twitter and LinkedIn. Josh LaRosa, MPP, is a policy director at Wynne Health Group, focusing primarily on regulatory affairs with a focus on the US Food & Drug Administration (FDA) and Centers for Medicare & Medicaid Services (CMS). His interests lie in delivery reform and innovations in payment and care delivery models. Josh also supports the firm’s Public Option Institute, which studies the emergence of public option programs at the state level. Prior to Wynne Health Group, Josh consulted for the CMS Innovation Center, where he worked to implement, monitor, and spread learning garnered from the center’s high-profile demonstration projects, most recently including the national primary care redesign effort, Comprehensive Primary Care Plus (CPC+). Josh holds a Master of Public Policy from the University of Virginia’s Frank Batten School of Leadership and Public Policy. He also completed his undergraduate studies at the University of Virginia, graduating cum laude with a BA in political philosophy, policy, and law. 02:56 Where are we on drug pricing reform in legislation? 05:06 What things have the greatest potential for consideration on drug pricing reform legislation? 06:07 How is the Part D benefit design and reform shaping up? 07:55 Who is one of the largest offenders of high federal spending? 09:15 Who is going to pay in the reform of the catastrophic pricing phase? 12:04 What are inflation rebates? 15:36 “The interesting part of the inflation rebates … is that it not only … had these inflation rebates as applying to … Medicare Part D drugs but also Medicare Part B … drugs.” 16:20 How likely is this reform? 18:43 What’s happening on the regulatory and administrative side of drug pricing? 24:23 When will we start to see what the White House intends to do about drug reform pricing? You can learn more at wynnehealth.com or by following on Twitter and LinkedIn. @josh_larosa of @WynneHealth talks #drugpricingreform on our #healthcarepodcast. #healthcare #podcast #digitalhealth #drugpricing #pharma Where are we on drug pricing reform in legislation? @josh_larosa of @WynneHealth talks #drugpricingreform on our #healthcarepodcast. #healthcare #podcast #digitalhealth #drugpricing #pharma What things have the greatest potential for consideration on drug pricing reform legislation? @josh_larosa of @WynneHealth talks #drugpricingreform on our #healthcarepodcast. #healthcare #podcast #digitalhealth #drugpricing #pharma How is the Part D benefit design and reform shaping up? @josh_larosa of @WynneHealth talks #drugpricingreform on our #healthcarepodcast. #healthcare #podcast #digitalhealth #drugpricing #pharma Who is one of the largest offenders of high federal spending? @josh_larosa of @WynneHealth talks #drugpricingreform on our #healthcarepodcast. #healthcare #podcast #digitalhealth #drugpricing #pharma Who is going to pay in the reform of the catastrophic pricing phase? @josh_larosa of @WynneHealth talks #drugpricingreform on our #healthcarepodcast. #healthcare #podcast #digitalhealth #drugpricing #pharma What are inflation rebates? @josh_larosa of @WynneHealth talks #drugpricingreform on our #healthcarepodcast. #healthcare #podcast #digitalhealth #drugpricing #pharma How likely is this latest drug pricing reform? @josh_larosa of @WynneHealth talks #drugpricingreform on our #healthcarepodcast. #healthcare #podcast #digitalhealth #drugpricing #pharma What’s happening on the regulatory and administrative side of drug pricing? @josh_larosa of @WynneHealth talks #drugpricingreform on our #healthcarepodcast. #healthcare #podcast #digitalhealth #drugpricing #pharma

Direct Contracting: A Physician's Perspective with Dr. Krishnan Narasimhan

The #HCBiz Show!

Play Episode Listen Later Mar 7, 2021 43:22

Direct Contracting is a new model from the Center for Medicare & Medicaid Innovation (CMMI, or the CMS Innovation Center) aimed at reducing expenditures and preserving or enhancing quality of care for beneficiaries in Medicare fee-for-service (FFS). At a minimum, it's an opportunity for providers to change the way they care for Medicare FFS patients. And if the Geographic Direct Contracting Model is launched (it's currently under review by CMS), it will be a sea change in the 10 targeted “Geo” regions. Either way, it's worth paying attention to. We covered the Direct Contracting model and options at length in Episode 156 with Gail Zahtz. You should start there if Direct Contracting is new to you. During that conversation, Zahtz identified plenty of areas where the model could benefit doctors and their patients. However, she identified several grey areas that make it difficult for physicians to engage with potential DCEs as the application deadline rapidly approaches (April 1, 2021). The timeline and lack of clarity make it difficult for a physician to evaluate the model and make a sound decision on how, or if to participate. So, that's our goal of this discussion. I talk with Dr. Krishnan Narasimhan, an academic family medicine physician and an Associate Professor in the Department of Community and Family Medicine at Howard University, about what Direct Contracting means to physicians. What opportunities does Direct Contracting create for physicians? What opportunities does Direct Contracting create for their patients? How does Direct Contracting compare to other value-based payment programs? How might Direct Contracting lead to deeper physician-payer alignment? How does Direct Contracting enable physicians to truly address the Social Determinants of Health (SDOH)? What questions should a physician ask a DCE to determine if they are a fit? What should physicians' do right now to determine if Direct Contracting is worth pursuing? How can busy physicians fit this in with all their existing priorities during a pandemic? Dr. Krishnan Narasimhan Krishnan Narasimhan M.D., is an academic family physician who has a proven record of driving health system and policy change. Dr. Narasimhan has led grassroots coalitions to move the political and policy debate on health reform, expand access, and to increase primary care infrastructure. He has spoken at the U.S. Capitol, at universities, and with numerous stakeholders on health reform, health disparities, and physician workforce. He serves on the Boards of Doctors for America and the District of Columbia Academy of Family Physicians. Dr. Narasimhan has a decade of experience in undergraduate and graduate medical education with a focus on curricular design, mentorship, and integrated care models. He has a record of consistently increasing primary care workforce capacity. His research on the Economic Impact of Family Physicians has been utilized extensively by the American Academy of Family Physicians. Currently he serves as Associate Professor at Howard University, Director of the Family Medicine Clerkship, as Residency faculty, and takes care of underserved populations. His training includes an M.D. from Jefferson Medical College, residency at University of Connecticut, Primary Care Health Policy Fellowship at Georgetown University, and a Certificate of Health Policy at the Georgetown Public Policy Institute. Dr. Narasimhan is also an advisor to WiseCare, a startup applying to become a Direct Contracting Entity (DCE). LinkedIn: https://www.linkedin.com/in/krishnanmd/ Links and Resources Doctors for America - Doctors for America mobilizes doctors and medical students to be leaders in putting patients over politics on the pressing issues of the day to improve the health of our patients, communities, and nation. District of Columbia Academy of Family Physicians: The District of Columbia Academy of Family Physicians (DCAFP) is a state chapter of the American Academy of Family Physicians. A membership organization for DC Family Physicians, the Academy advocates for Family Physicians and our patients, and conducts continuing medical education for Family Physicians. Episode 156: Direct Contracting: It's Coming Fast and Will Have a Big Impact on Medicare-fee-for-service w/ Gail Zahtz – you'll find additional Direct Contracting resources there. WiseCare The #HCBiz Show! is produced by Glide Health IT, LLC in partnership with Netspective Media.

ET3: An Innovative Program for EMS

iCHIEFS

Play Episode Listen Later May 28, 2020 33:00

Emergency Triage, Treat, and Transport (ET3), is a new initiative led by the Centers for Medicare and Medicaid Services' (CMS) Innovation Center. ET3 offers treatment and transportation alternatives for emergency medical service (EMS) providers serving Medicare Fee for Services (FFS) beneficiaries. Fire Chief John SInclair, Kittitas Valley (WA) Fire & Rescue, Division Chief Peter Lawrence, Oceanside (CA) and Senior Consultant Maggie Dunham, Public Consulting Group, discuss: How departments can participate in ET3 Potential benefits and drawbacks from participating in this initiative The value in testing the viability of alternatives for triage, treatment, and transport The importance of reporting quality and performance measures, HIE, and multi-payer strategies. Where we go from here if the approved projects are successful To hear past ICHIEFS podcasts, visit blogtalkradio.com/ichiefs

treat innovative medicare centers firefighters ems firefighting fire chief medicaid services fire service hie oceanside ca et3 cms innovation center

AEE10: An Update on the Snowball of Drug Pricing Initiatives in Washington Right Now, With Josh LaRosa, MPP, Policy Director, Wynne Health Group